# Woori Financial Group Inc.: financial statements, quarterly

WF · NYSE · CIK 1264136 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/wf.md) · [Financials](/companies/wf/financials.md) · [Filings](/companies/wf/filings.md) · [Insiders](/companies/wf/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/wf/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2009-12-31) | FY2010 (2010-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [14.7](/filings/0000950123-11-066669.md) | [14.1](/filings/0000950123-11-066669.md) | [7.1](/filings/0001193125-18-141139.md) | [6.2](/filings/0001193125-19-128772.md) | [5.8](/filings/0001193125-20-124619.md) | [5.9](/filings/0001193125-21-142293.md) | [8.4](/filings/0001193125-22-150789.md) | [16.4](/filings/0001193125-23-109119.md) | [26.5](/filings/0001193125-24-119661.md) | [20.7](/filings/0001193125-25-098257.md) | [18.5](/filings/0001193125-25-098257.md) |
| Total assets | $bn | not reported | [241](/filings/0000950123-11-066669.md) | not reported | [296](/filings/0001193125-18-141139.md) | [306](/filings/0001193125-19-128772.md) | [313](/filings/0001193125-20-124619.md) | [367](/filings/0001193125-21-142293.md) | [376](/filings/0001193125-22-150789.md) | [381](/filings/0001193125-23-109119.md) | [386](/filings/0001193125-24-119661.md) | [356](/filings/0001193125-25-098257.md) |
| Total liabilities | $bn | not reported | [229](/filings/0000950123-11-066669.md) | not reported | [277](/filings/0001193125-18-141139.md) | [286](/filings/0001193125-19-128772.md) | [291](/filings/0001193125-20-124619.md) | [343](/filings/0001193125-21-142293.md) | [352](/filings/0001193125-22-150789.md) | [356](/filings/0001193125-23-109119.md) | [360](/filings/0001193125-24-119661.md) | [331](/filings/0001193125-25-098257.md) |
| Shareholders' equity | $bn | not reported | [12.4](/filings/0000950123-11-066669.md) | [19.2](/filings/0001193125-18-141139.md) | [19.1](/filings/0001193125-18-141139.md) | [19.5](/filings/0001193125-19-128772.md) | [18.6](/filings/0001193125-20-124619.md) | [21.2](/filings/0001193125-21-142293.md) | [21.7](/filings/0001193125-22-150789.md) | [22.8](/filings/0001193125-23-109119.md) | [24.5](/filings/0001193125-24-119661.md) | [23.1](/filings/0001193125-25-098257.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue, ifrs-full:CashAndCashEquivalents
- Total assets: us-gaap:Assets, ifrs-full:Assets
- Total liabilities: us-gaap:Liabilities, ifrs-full:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 734,022,375 at 2025-12-31, from the cover of the [20-F filed 2026-04-22](/filings/0001193125-26-168715.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.